Combining Expertise for Healthcare Solutions
The partnership will focus on leveraging BioSurfaces' unique properties to advance innovations in regenerative medicine. By combining BioSurfaces' expertise in biomaterials with Morphocell's deep knowledge in cell-based therapies, the companies seek to develop new solutions that address critical healthcare challenges.
Morphocell’s Perspective on BioSurfaces’ Material
"At Morphocell, we are always looking for cutting-edge technologies that can help us improve patient outcomes," said Dr. Massimiliano Paganelli, CEO of Morphocell. "BioSurfaces has developed an exciting material, and we look forward to working together to explore its potential in advancing therapeutic approaches for patients in need."
Excitement at BioSurfaces Regarding the Partnership
Matthew Phaneuf, President and CEO of BioSurfaces, added: "We are excited to collaborate with Morphocell, a company at the forefront of regenerative medicine. Our shared mission is to innovate and develop solutions that can ultimately improve lives. This partnership represents an important step in that direction."
Focus on Early-Stage Research for Therapeutic Applications
The collaboration will focus on early-stage research efforts to evaluate Bio-Spun in various therapeutic applications, with the long-term vision of contributing to the advancement of regenerative treatments for patients worldwide.
